BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$25.88 USD
-0.40 (-1.52%)
Updated Sep 19, 2025 12:04 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BLFS 25.88 -0.40(-1.52%)
Will BLFS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
Are Medical Stocks Lagging Bayer (BAYRY) This Year?
Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Envista, BioLife Solutions, InfuSystems and MariMed
4 Medical Product Stocks to Watch From a Challenging Industry
BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why
Other News for BLFS
Is BLFS set to rally? Crossed Above 20 Day Moving Average shows up after gaining 2.72%
Fell Below 20 Day Moving Average appears for BLFS after 1.52% move
Is BLFS set to rally? 20 Day Moving Average Support shows up after climbing 0.7%
Insider Sell: Sarah Aebersold Sells Shares of BioLife Solutions Inc (BLFS)
20 Day Moving Average Support appears for BLFS after 1.14% move